Abstract
The Food and Drug Administration has approved the first generic version of Restasis, the cyclosporine ophthalmic emulsion eye drops used to treat dry eye.The generic version is expected to provide cost savings for patients, especially those whose insurance does not cover Restasis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
